Secondary debulking in recurrent ovarian cancer is a highly debated topic due to controversies in large published studies with varying outcomes and patient selection. Please join us while we review GOG-0213, DESKTOP III, and SOC 1 study designs, outcomes and conclusions with experts in our field while we explore their perspectives and interpretations on the topic.

Speakers:
Dennis Chi, MD
Amer Karam, MD
Emma Rossi, MD

Moderators:
Stephanie Sullivan, MD
Whitney Goldsberry, MD

Recorded on April 26, 2022.